Albert Robichaud

Insider Reports History

Entity
Individual
Location
215 First Street, Cambridge, MA
Signature
/s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Albert Robichaud
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Albert Robichaud:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sage Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 16.7K Feb 13, 2023 Direct

Insider Reports Filed by Albert Robichaud

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SAGE Sage Therapeutics, Inc. Feb 13, 2023 1 $0 4 Feb 15, 2023 Chief Scientific Officer
SAGE Sage Therapeutics, Inc. Feb 3, 2023 2 -$49.8K 4 Feb 7, 2023 Chief Scientific Officer
SAGE Sage Therapeutics, Inc. Feb 11, 2022 1 $0 4 Feb 15, 2022 Chief Scientific Officer
SAGE Sage Therapeutics, Inc. Oct 19, 2021 2 -$45K 4 Oct 21, 2021 Chief Scientific Officer
SAGE Sage Therapeutics, Inc. Jun 15, 2021 2 -$67.3K 4 Jun 17, 2021 Chief Scientific Officer